Skip to main content
. 2021 Aug 5;14(8):770. doi: 10.3390/ph14080770

Figure 5.

Figure 5

3D scheme of the ligand-ABL kinase receptor interactions. In red, tested molecule (A) catechin, (B) epicatechin, (C) epicatechin gallate, (D) epigallocatechin, (E) gallocatechin, (F) oleuropein, (G) rutin, (H) vanillic acid, (I) chlorogenic acid; in black, reference molecule (nilotinib) and labeled amino acid residues interacting with the tested molecule.